Clinical Trial

An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)

Name: An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED) — clinical trial record (NCT07462130)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Multicentre, Phase Ib/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of NTB003 in Participants with Thyroid Eye Disease

Trial Details

NCT Number	NCT07462130
Lead Sponsor	Nanjing Chia-tai Tianqing Pharmaceutical
Conditions	Thyroid Eye Disease
Enrollment	74 participants
Start Date	2026-03-01
Primary Completion	2027-05-31 (estimated)
Study Completion	2028-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-10